NCT05070663View on ClinicalTrials.gov

A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

March 14, 2024

Study Completion Date

March 3, 2025

Conditions
Asthma
Trial Locations (1)

Unknown

Investigational site France, France

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05070663 - A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®) | Biotech Hunter | Biotech Hunter